Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (113934) 113934
Publication (8379) 8379
Newsletter (5282) 5282
Book Review (1047) 1047
Book Chapter (429) 429
Conference Proceeding (218) 218
Newspaper Article (206) 206
Book / eBook (181) 181
Magazine Article (144) 144
Dissertation (74) 74
Web Resource (28) 28
Government Document (14) 14
Trade Publication Article (14) 14
Transcript (14) 14
Data Set (12) 12
Reference (12) 12
Journal / eJournal (9) 9
Presentation (9) 9
Paper (6) 6
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88234) 88234
female (59886) 59886
index medicus (44937) 44937
middle aged (41968) 41968
oncology (41844) 41844
male (39432) 39432
cancer (36569) 36569
aged (34629) 34629
adult (33441) 33441
chemotherapy, adjuvant (32362) 32362
treatment outcome (23565) 23565
surgery (22195) 22195
chemotherapy (21910) 21910
adjuvant treatment (19115) 19115
prognosis (18227) 18227
neoplasm staging (18015) 18015
breast cancer (17713) 17713
radiotherapy, adjuvant (16774) 16774
care and treatment (16572) 16572
radiotherapy (15540) 15540
antineoplastic combined chemotherapy protocols - therapeutic use (15524) 15524
combined modality therapy (14542) 14542
retrospective studies (14476) 14476
research (14379) 14379
animals (14103) 14103
adjuvant chemotherapy (13870) 13870
aged, 80 and over (12993) 12993
survival (12667) 12667
breast neoplasms - drug therapy (12014) 12014
follow-up studies (11256) 11256
health aspects (10760) 10760
disease-free survival (10525) 10525
therapy (10519) 10519
analysis (10216) 10216
survival rate (10014) 10014
carcinoma (9958) 9958
medicine & public health (9221) 9221
breast neoplasms - pathology (9010) 9010
survival analysis (8547) 8547
risk factors (8488) 8488
antineoplastic agents - therapeutic use (8236) 8236
neoadjuvant therapy (8234) 8234
adjuvants, immunologic - therapeutic use (7533) 7533
tumors (7413) 7413
mice (7168) 7168
time factors (7166) 7166
adjuvant therapy (7116) 7116
oncology, experimental (7070) 7070
radiation-therapy (6904) 6904
adolescent (6707) 6707
metastasis (6098) 6098
breast neoplasms - surgery (5976) 5976
lymphatic metastasis (5739) 5739
hematology, oncology and palliative medicine (5737) 5737
women (5649) 5649
prospective studies (5524) 5524
trial (5479) 5479
immunology (5406) 5406
recurrence (5405) 5405
drug therapy (5366) 5366
adjuvant (5142) 5142
cancer patients (5047) 5047
colorectal cancer (4912) 4912
randomized-trial (4862) 4862
radiology, nuclear medicine & medical imaging (4761) 4761
pharmacology & pharmacy (4752) 4752
immunotherapy (4721) 4721
young adult (4714) 4714
radiation (4694) 4694
patient outcomes (4603) 4603
fluorouracil - administration & dosage (4311) 4311
management (4251) 4251
child (4246) 4246
kaplan-meier estimate (4140) 4140
obstetrics & gynecology (4115) 4115
patients (4115) 4115
randomized controlled trials as topic (4057) 4057
tamoxifen (4054) 4054
radiation therapy (4036) 4036
diagnosis (4029) 4029
adjuvants, immunologic - administration & dosage (3992) 3992
breast neoplasms - therapy (3961) 3961
neoadjuvant chemotherapy (3950) 3950
clinical trials (3870) 3870
abridged index medicus (3869) 3869
neoplasm recurrence, local (3835) 3835
antineoplastic combined chemotherapy protocols - adverse effects (3783) 3783
medicine, general & internal (3777) 3777
multivariate analysis (3772) 3772
clinical trials as topic (3767) 3767
adenocarcinoma (3760) 3760
immunohistochemistry (3758) 3758
expression (3750) 3750
article (3737) 3737
radiotherapy dosage (3720) 3720
breast neoplasms - radiotherapy (3693) 3693
breast neoplasms - mortality (3659) 3659
risk (3620) 3620
cancer therapies (3605) 3605
cisplatin - administration & dosage (3584) 3584
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (123) 123
Online Resources - Online (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
UofT at Mississauga - Stacks (5) 5
UTL at Downsview - May be requested (3) 3
Gerstein Science - Periodical Stacks (2) 2
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Special Collections (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Bindery (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (107872) 107872
German (3097) 3097
French (2240) 2240
Russian (1957) 1957
Japanese (1748) 1748
Chinese (824) 824
Spanish (546) 546
Polish (447) 447
Italian (423) 423
Hungarian (243) 243
Dutch (100) 100
Danish (90) 90
Korean (85) 85
Czech (83) 83
Portuguese (71) 71
Romanian (67) 67
Ukrainian (67) 67
Bulgarian (59) 59
Turkish (50) 50
Norwegian (39) 39
Swedish (34) 34
Finnish (32) 32
Hebrew (21) 21
Slovak (16) 16
Lithuanian (14) 14
Serbian (11) 11
Croatian (10) 10
Icelandic (6) 6
Arabic (4) 4
Bosnian (3) 3
Slovenian (3) 3
Persian (2) 2
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Early Salvage Hormonal Therapy for Biochemical Failure Improved Survival in Prostate Cancer Patients After Neoadjuvant Hormonal Therapy Plus Radiation Therapy—A Secondary Analysis of Irish Clinical Oncology Research Group 97-01
by Mydin, Aminudin R., MBBS, FRCR and Dunne, Mary T., MSc and Finn, Marie A and Armstrong, John G., FFRRCSI
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text DEGRO practical guidelines: Radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
by Sedlmayer, F and Sautter-Bihl, M.-L and Budach, W and Dunst, J and Fastner, G and Feyer, P and Fietkau, R and Haase, W and Harms, W and Souchon, R and Wenz, F and Sauer, R and Breast Canc Expert Panel German and Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)
Strahlentherapie und Onkologie, ISSN 0179-7158, 10/2013, Volume 189, Issue 10, pp. 825 - 833
Background and purpose. The aim of the present paper is to update the practical guidelines for postoperative adjuvant radiotherapy of breast cancer published... 
Boost radiotherapy | Whole breast irradiation | Breast conserving therapy | Fractionation | Partial breast radiotherapy | LUMPECTOMY PLUS TAMOXIFEN | RADIATION ONCOLOGY | EARLY-STAGE | UK STANDARDIZATION | INTRAOPERATIVE RADIOTHERAPY | NEOADJUVANT CHEMOTHERAPY | LOCAL RECURRENCE | ONCOLOGY | WHOLE-BREAST | ADJUVANT RADIOTHERAPY | CONSENSUS STATEMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Breast Neoplasms - therapy | Combined Modality Therapy - standards | Neoplasm Invasiveness | Humans | Medical Oncology - standards | Female | Radiotherapy, Adjuvant - standards | Mastectomy, Segmental - standards | Germany | Radiotherapy, Conformal - standards | Lumpectomy | Care and treatment | Breast cancer | Radiotherapy | Health aspects | Cancer | Brusterhaltende Therapie | Ganzbrustbestrahlung | Partialbrustbestrahlung | Boostbestrahlung | Fraktionierung | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
by Coates, Alan S and Winer, Eric P and Goldhirsch, Aron and Gelber, Richard D and Gnant, Michael and Piccart-Gebhart, Martine J and Thürlimann, Beat and Senn, H.-J and André, Fabrice and Baselga, José and Bergh, Jonas and Bonnefoi, Hervé and Burstein, Harold and Cardoso, Fatima and Castiglione-Gertsch, Monica and Colleoni, Marco and Curigliano, Giuseppe and Davidson, Nancy E and Leo, Angelo Di and Ejlertsen, Bent and Forbes, John F and Galimberti, Viviana and Goodwin, Pamela and Harbeck, Nadia and Hayes, Daniel F and Huober, Jens and Hudis, Clifford A and Ingle, James N and Jassem, Jacek and Jiang, Zefei and Karlsson, Per and Morrow, Monica and Orecchia, Roberto and Kent Osborne, C and Partridge, Ann H and de la Peña, Lorena and Pritchard, Kathleen I and Rutgers, Emiel J.T and Sedlmayer, Felix and Semiglazov, Vladimir and Shao, Zhi-Ming and Smith, Ian and Toi, Masakazu and Tutt, Andrew and Viale, Giuseppe and von Minckwitz, Gunter and Watanabe, Toru and Whelan, Timothy and Xu, Binghe and Panel Members
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast... 
Radiation therapy | Early breast cancer | St Gallen Consensus | Systemic adjuvant therapies | Surgery | early breast cancer | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | radiation therapy | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | systemic adjuvant therapies | surgery | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Long-Term Outcome After Radiotherapy in Patients With Atypical and Malignant Meningiomas—Clinical Results in 85 Patients Treated in a Single Institution Leading to Optimized Guidelines for Early Radiation Therapy
by Adeberg, Sebastian and Hartmann, Christian, M.D and Welzel, Thomas, M.D and Rieken, Stefan, M.D and Habermehl, Daniel, M.D and von Deimling, Andreas, M.D and Debus, Jürgen, M.D., Ph.D and Combs, Stephanie E., M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 859 - 864
Purpose Previously, we could show that the new World Health Organization (WHO) classification of meningiomas significantly correlated with outcome in patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation therapy | Outcome | High-risk meningiomas | Prognostic factors | SKULL-BASE | MANAGEMENT | INTRACRANIAL MENINGIOMAS | PROGNOSTIC-FACTORS | INTENSITY-MODULATED RADIOTHERAPY | RADIOSURGERY | FRACTIONATED STEREOTACTIC RADIOTHERAPY | ONCOLOGY | EXPERIENCE | GRADE-I MENINGIOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICOPATHOLOGICAL FEATURES | Prognosis | Humans | Meningioma - surgery | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Carbon Radioisotopes - therapeutic use | Male | Treatment Outcome | Disease Progression | Meningeal Neoplasms - mortality | Disease-Free Survival | Meningioma - pathology | Karnofsky Performance Status | Meningeal Neoplasms - surgery | Dose Fractionation | Female | Meningeal Neoplasms - radiotherapy | Meningioma - radiotherapy | Meningeal Neoplasms - pathology | Radiosurgery - methods | Radiotherapy, Adjuvant | Meningioma - mortality | Practice Guidelines as Topic | Nuclear radiation | Oncology, Experimental | Radiation | Research | Universities and colleges | Radiotherapy | Public health | Cancer | SURGERY | DIAGNOSIS | PATIENTS | NEOPLASMS | PERFORMANCE | CLASSIFICATION | RADIATION DOSES | SYMPTOMS | HISTOLOGY | COMPUTERIZED TOMOGRAPHY | GY RANGE 10-100 | NMR IMAGING | RECOMMENDATIONS | RADIOLOGY AND NUCLEAR MEDICINE | CARBON IONS | RADIOTHERAPY | HAZARDS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Therapeutic Strategies in Targeted Therapies in Breast Cancer
by Sledge, G. W
2012, ISBN 1846920663, 176
Book
Details down arrow
6. Full Text Current standards and new innovative approaches for treatment of pancreatic cancer
by Conroy, Thierry and Bachet, Jean-Baptiste and Ayav, Ahmet and Huguet, Florence and Lambert, Aurélien and Caramella, Caroline and Maréchal, Raphaël and Van Laethem, Jean-Luc and Ducreux, Michel
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 57, pp. 10 - 22
Abstract Pancreatic adenocarcinoma remains a devastating disease with a 5-year survival rate not exceeding 6%. Treatment of this disease remains a major... 
Hematology, Oncology and Palliative Medicine | Chemotherapy | Staging | Targeted therapy | Pancreatic cancer | Surgery | Imaging | Radiotherapy | ADJUVANT CHEMOTHERAPY | DUCTAL ADENOCARCINOMA | MORTALITY PREDICTIONS | CURATIVE RESECTION | NEOADJUVANT THERAPY | FOLINIC ACID | PHASE-III TRIAL | ONCOLOGY | QUALITY-OF-LIFE | NUCLEOSIDE TRANSPORTER 1 | CONSENSUS STATEMENT | Therapies, Investigational - methods | Adenocarcinoma - pathology | Humans | Neoplasm Recurrence, Local - therapy | Pancreatic Neoplasms - pathology | Diagnostic Imaging - methods | Neoplasm Recurrence, Local - pathology | Reference Standards | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Neoplasm Staging | Molecular Targeted Therapy - methods | Precision Medicine - methods | Palliative Care - methods | Pancreatic Neoplasms - therapy | Drug therapy | Health aspects | Adjuvant treatment | Cancer | Index Medicus | Adenocarcinoma | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols | Therapies, Investigational | Palliative Care | Molecular Targeted Therapy | Life Sciences | Diagnostic Imaging | Neoadjuvant Therapy | Santé publique et épidémiologie | Chemotherapy, Adjuvant | Pancreatic Neoplasms | Precision Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
by Carrie, Christian, Dr and Hasbini, Ali, MD and de Laroche, Guy, MD and Richaud, Pierre, MD and Guerif, Stéphane, MD and Latorzeff, Igor, MD and Supiot, Stéphane, PhD and Bosset, Mathieu, MD and Lagrange, Jean-Léon, Prof and Beckendorf, Véronique, MD and Lesaunier, François, MD and Dubray, Bernard, Prof and Wagner, Jean-Philippe, MD and N'Guyen, Tan Dat, Prof and Suchaud, Jean-Philippe, MD and Créhange, Gilles, Prof and Barbier, Nicolas, MD and Habibian, Muriel, MSc and Ferlay, Céline, MSc and Fourneret, Philippe, MD and Ruffion, Alain, Prof and Dussart, Sophie, MD
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Summary Background How best to treat rising prostate-specific antigen (PSA) concentration after radical prostatectomy is an urgent clinical question. Salvage... 
Hematology, Oncology and Palliative Medicine | ANDROGEN DEPRIVATION | ONCOLOGY | BIOCHEMICAL RECURRENCE | FOLLOW-UP | RISK | NATURAL-HISTORY | CANCER | PROGRESSION | RADIATION-THERAPY | PSA | ADJUVANT | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - surgery | Aged, 80 and over | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Prostatic Neoplasms - surgery | Adenocarcinoma - blood | Survival Rate | Combined Modality Therapy | Adenocarcinoma - drug therapy | Prostate-Specific Antigen - blood | Biomarkers, Tumor - blood | Androgen Antagonists - therapeutic use | Radiotherapy, Conformal | Prostatectomy | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Radiotherapy | Antigens | Surgery | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
by Stupp, Roger and Taillibert, Sophie and Kanner, Andrew A and Kesari, Santosh and Steinberg, David M and Toms, Steven A and Taylor, Lynne P and Lieberman, Frank and Silvani, Antonio and Fink, Karen L and Barnett, Gene H and Zhu, Jay-Jiguang and Henson, John W and Engelhard, Herbert H and Chen, Thomas C and Tran, David D and Sroubek, Jan and Tran, Nam D and Hottinger, Andreas F and Landolfi, Joseph and Desai, Rajiv and Caroli, Manuela and Kew, Yvonne and Honnorat, Jerome and Idbaih, Ahmed and Kirson, Eilon D and Weinberg, Uri and Palti, Yoram and Hegi, Monika E and Ram, Zvi
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
IMPORTANCE: Glioblastoma is the most devastating primary malignancy of the central nervous system in adults. Most patients die within 1 to 2 years of... 
PHASE-III TRIAL | ALTERNATING ELECTRIC-FIELDS | NOVOTTF-100A | MEDICINE, GENERAL & INTERNAL | TREATMENT MODALITY | NEWLY-DIAGNOSED GLIOBLASTOMA | RECURRENT GLIOBLASTOMA | OPEN-LABEL | QUALITY-OF-LIFE | RADIOTHERAPY | ADJUVANT TEMOZOLOMIDE | Dacarbazine - therapeutic use | United States | Humans | Middle Aged | Male | Chemoradiotherapy | Young Adult | Early Termination of Clinical Trials | Carmustine - therapeutic use | Maintenance Chemotherapy - methods | Dacarbazine - analogs & derivatives | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Republic of Korea | Europe | Combined Modality Therapy - adverse effects | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Canada | Disease-Free Survival | Electric Stimulation Therapy - methods | Electric Stimulation Therapy - adverse effects | Brain Neoplasms - therapy | Aged | Combined Modality Therapy - methods | Israel | Glioblastoma - mortality | Patient safety | Brain cancer | Medical treatment | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Antitumor drug-radiation interactions
by Hill, Bridget T and Bellamy, Angela S
1990, ISBN 9780849346200, 284
Chemotherapy | Antineoplastic agents | Radiotherapy | Adjuvant therapy | Cancer
Book
Details down arrow
10. Full Text Radiation therapy (RT) after breast-conserving surgery (BCS) in 2015 – The year of radiation therapy advances
by Kirova, Y.M
European Journal of Surgical Oncology, ISSN 0748-7983, 2016, Volume 42, Issue 4, pp. 437 - 440
Abstract Surgery associated with radiation therapy is the standard treatment for early breast cancer. This paper reviews the new evidence on local control and... 
Hematology, Oncology and Palliative Medicine | Surgery | Breast cancer | Radiation therapy | Survival | Breast-conserving surgery | New techniques | SURGERY | BOOST | VOLUME | PHASE-3 | TRIAL | IRRADIATION | DELINEATION | ONCOLOGY | INTERNAL MAMMARY | BRACHYTHERAPY | Breast Neoplasms - surgery | Breast Neoplasms - radiotherapy | Humans | Dose Fractionation | Female | Postoperative Care - methods | Radiotherapy, Adjuvant | Mastectomy, Segmental - methods | Lumpectomy | Football (College) | Radiotherapy | Radiation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comparison of intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy as adjuvant therapy for gastric cancer
by Minn, A. Yuriko and Hsu, Annie and La, Trang and Kunz, Pamela and Fisher, George A and Ford, James M and Norton, Jeffrey A and Visser, Brendan and Goodman, Karyn A and Koong, Albert C and Chang, Daniel T
Cancer, ISSN 0008-543X, 08/2010, Volume 116, Issue 16, pp. 3943 - 3952
BACKGROUND: The current study was performed to compare the clinical outcomes and toxicity in patients treated with postoperative chemoradiotherapy for gastric... 
adjuvant therapy | gastric | intensity‐modulated radiotherapy (IMRT) | radiation outcomes | Radiation outcomes | Gastric | Intensity-modulated radiotherapy (IMRT) | Adjuvant therapy | FRACTIONATION | intensity-modulated radiotherapy (IMRT) | IMRT | ONCOLOGY | RESECTION | PATTERNS | PLAN | RADIATION | FAILURE | Stomach Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - adverse effects | Aged, 80 and over | Adult | Female | Radiotherapy, Conformal - adverse effects | Aged | Radiotherapy, Adjuvant | Stomach Neoplasms - surgery | Radiotherapy, Conformal - methods | Care and treatment | Patient outcomes | Intensity-modulated radiotherapy | Research | Radiotherapy | Comparative analysis | Stomach cancer | Methods | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Drug therapy: Systemic therapy for colorectal cancer
by Meyerhardt, Jeffrey A and Mayer, Robert J
New England Journal of Medicine, ISSN 0028-4793, 02/2005, Volume 352, Issue 5, pp. 476 - 487
GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | SYNTHASE PROTEIN EXPRESSION |